OGN Chart

1 Month

	Date	Diff
	2025-05-02	+1.48 %
Organon & Co. (OGN) stock rose by 1.48% following the company's better-than-expected quarterly earnings report, which revealed an EPS of $1.02, surpassing the consensus estimate and indicating strong market performance despite a slight decline in revenue. Organon & Co. (OGN) stock rose 1.48% following stronger-than-expected quarterly earnings, with an EPS of $1.02 beating the consensus estimate and a robust dividend yield, attracting interest from institutional investors. The article discusses the investigation by Robbins Geller Rudman & Dowd LLP into potential securities law violations by Organon & Co. (OGN) and notes that the company recently cut its dividend by approximately 90%, leading to a significant drop in its stock price. Despite this, Organon stock rose 1.48% last night, likely due to investor sentiment recovering after the initial negative reaction to the dividend cut or potential speculation on future company performance improvements.
	2025-04-25	+0.66 %
Organon & Co. (OGN) stock rose by 0.66% following significant increases in institutional investments, with Envestnet Asset Management growing its stake by over 203% and other hedge funds also increasing their holdings, reflecting growing confidence in the company's prospects.
	2025-04-17	+2.77 %
Organon & Co. (OGN) stock increased by 2.77% due to significant institutional buying, as several hedge funds boosted their positions in the company during the fourth quarter, indicating growing investor confidence.
	2025-04-15	-2.21 %
Organon & Co. (OGN) stock fell by 2.21% primarily due to disappointing earnings results that missed analysts' expectations, influencing investor sentiment negatively despite increased institutional investments in the company.
	2025-04-14	+1.07 %
Organon & Co. (OGN) stock rose by 1.07% as institutional investors like Vanguard and Pacer Advisors significantly increased their holdings during the fourth quarter, indicating growing confidence in the company's performance and prospects.
	2025-04-10	-9.57 %
Shares of Organon & Co. (OGN) fell by 9.57% amid a mixture of analyst reports resulting in lowered price targets and a consensus "Hold" recommendation, which may have raised concerns among investors about the company’s future performance.
	2025-04-08	-6.95 %
Organon & Co. (OGN) stock decreased by 6.95% due to a combination of a disappointing earnings report that missed consensus estimates and recent price target cuts from research firms, suggesting a bearish outlook for the stock. Organon & Co. (OGN) stock fell by 6.95% likely due to missing earnings expectations in their recent quarterly report, which may have influenced investor sentiment amid mixed ratings and financial outlooks from analysts.
	2025-04-07	-4.06 %
Organon & Co. (NYSE: OGN) stock fell by -4.06% due to disappointing quarterly earnings, which missed analysts' expectations, and a series of downgrades from financial analysts regarding its stock price targets.
	2025-04-02	+4.18 %
Organon & Co. (OGN) stock increased by 4.18% partly due to Vanguard Group Inc.'s modest increase in its shares and changes in institutional investors' holdings, along with recent research analyst ratings and a solid dividend announcement.
	2025-04-01	-5.1 %
Organon & Co. (OGN) stock fell by 5.1% following a reduction in price targets by several research firms, along with missing earnings estimates in the last quarterly report.
	2025-03-28	-0.34 %
Organon & Co. (OGN) stock declined by 0.34% following a significant reduction in its shares held by Natixis Advisors LLC and mixed reactions from analysts regarding the company's earnings performance and future outlook.
	2025-03-27	-1.02 %
Organon & Co. (OGN) fell by 1.02% amid reports of various hedge funds adjusting their stakes in the company, including Thrivent Financial for Lutherans reducing its holdings, and due to disappointing earnings results that missed consensus estimates, contributing to negative sentiment around the stock. Organon & Co. (OGN) stock experienced a decline of 1.02% partly due to recent downgrades in target prices by analysts, with Morgan Stanley reducing its target from $17 to $16 and Barclays from $26 to $24, reflecting a cautious outlook on the company's performance.
	2025-03-21	-1.35 %
Organon & Co. (OGN) stock fell by -1.35% after Sequoia Financial Advisors LLC significantly reduced its holdings in the company by 52.6%, indicating potential negative sentiment among institutional investors despite some hedge funds increasing their stakes. Organon & Co. (OGN) stock decreased by 1.35% due to a combination of missed earnings expectations and analysts lowering their price targets, reflecting a cautious outlook on the company's performance.
	2025-03-18	+0.51 %
Organon & Co. (OGN) stock increased by 0.51% following a series of institutional investments as hedge funds adjusted their positions, with significant investments and positive market activities contributing to the stock's performance.
	2025-03-14	+2.34 %
Organon & Co. (OGN) stock rose 2.34% due to a combination of increased institutional investment in the company and a recently announced dividend, despite analysts maintaining a "Hold" rating with mixed opinions on its price targets. Organon & Co. (OGN) stock rose 2.34% likely due to recent institutional investors increasing their stakes in the company, indicating positive sentiment amidst mixed earnings results and attractive dividend yields. Organon & Co. (OGN) stock rose by 2.34% due to significant increases in institutional holdings during the fourth quarter, highlighting growing investor interest and confidence in the company's prospects.
	2025-03-12	-3.85 %
Organon & Co. (OGN) stock declined by 3.85% due to analysts reducing their target prices for the stock, with notable downgrades from Barclays and Morgan Stanley, following a quarterly earnings report that missed consensus estimates.
	2025-03-06	+2.84 %
Organon & Co. (OGN) stock rose by 2.84% due to significant institutional investor activity, with some hedge funds greatly increasing their stakes in the company, despite mixed ratings and a recent earnings miss.
	2025-02-27	-2.84 %
Organon & Co. (OGN) stock fell by 2.84% following the company's recent earnings report, which revealed a miss in earnings per share compared to analyst expectations, despite a slight revenue beat.
	2025-02-26	-4.03 %
Organon & Co. (OGN) stock declined by 4.03% partly due to a disappointing quarterly earnings report that missed analysts' expectations, in addition to ongoing adjustments in institutional investors' stakes in the company.
	2025-02-25	+6.96 %
Organon & Co. (OGN) stock rose by 6.96% following an increase in institutional ownership, with Principal Financial Group Inc. boosting its stake and other investors reinforcing their positions, contributing to positive market sentiment despite a recent earnings miss.
	2025-02-12	-1.67 %
Organon & Co. (OGN) stock decreased by 1.67%, influenced by varying activities of institutional investors and a consensus rating change to "hold" by TD Cowen, amid a broader backdrop of hedge fund adjustments to their positions in the company.
	2025-02-04	+0.2 %
Organon & Co. (OGN) stock rose by 0.2% following significant investments and stake acquisitions by institutional investors, indicating increased institutional confidence in the company's potential.
	2025-01-30	+0.82 %
The article discusses recent changes in institutional holdings for Organon & Co. (OGN), highlighting a significant reduction by Exchange Traded Concepts LLC, while other investors increased their stakes, and mentions that the stock rose by 0.82% due to a mix of buying interest and a rating upgrade by TD Cowen to "hold." The rise in Organon & Co. (OGN) stock can be attributed to increased institutional investor interest and a favorable rating adjustment from TD Cowen.
	2025-01-17	-2.72 %
Organon & Co. (OGN) stock fell by 2.72% primarily due to a recent earnings report that showed the company missed earnings expectations, despite a slight increase in revenue compared to the previous year.
	2025-01-15	-0.51 %
Organon & Co. (OGN) stock decreased by 0.51% following a 25.5% reduction in holdings by Eagle Bay Advisors LLC, indicating potential concerns among institutional investors regarding the company's financial performance despite an upgrade to "strong-buy" from Evercore ISI.
	2025-01-13	-1.2 %
Organon & Co. (OGN) stock decreased by 1.2% following Graypoint LLC's reduction of its holdings in the company by 28.1%, along with mixed earnings reports that missed consensus estimates.
	2025-01-10	-0.94 %
Organon & Co. (OGN) stock fell by 0.94% as Everence Capital Management significantly decreased its holdings, selling over 22,000 shares, which may have influenced market sentiment negatively.
	2025-01-07	+1.55 %
Organon & Co. (OGN) stock increased by 1.55% largely due to institutional investors, including Nordea Investment Management AB, expanding their holdings, which reflects confidence in the company's financial performance and future prospects. Organon & Co. (OGN) stock increased by 1.55% following a significant boost in stake by Versant Capital Management Inc. and positive investor sentiment reflected by multiple new investments from large institutional investors, indicating confidence in the company’s growth potential and its recent quarterly performance, despite a slight earnings miss.
	2024-12-19	-0.48 %
Organon & Co. (OGN) stock dipped by 0.48% following a report that the Public Employees Retirement System of Ohio reduced its stake in the company by 4.7%, alongside mixed earnings results indicating a slight miss on earnings expectations.
	2024-12-16	-4.71 %
Organon & Co. (OGN) stock fell by 4.71% due to a downgrade from JPMorgan Chase & Co. from "neutral" to "underweight" and missing earnings estimates, despite reporting revenue growth and maintaining a robust dividend yield.
	2024-12-06	-2.83 %
Organon & Co. (OGN) stock declined by 2.83% likely due to negative analyst sentiment, specifically a downgrade from JPMorgan Chase & Co., coupled with a missed earnings target in their recent quarterly report.
	2024-12-02	-1.89 %
Organon & Co. (OGN) stock dropped by -1.89% following a report of institutional investors adjusting their holdings, including a downgrade from JPMorgan Chase & Co. which changed its rating from "neutral" to "underweight" and increased its target price for the stock.
	2024-11-18	+0.47 %
Organon & Co. (OGN) stock increased by 0.47% following a significant stake purchase by Crossmark Global Holdings Inc., which raised its holdings in the company by 43.4%, along with other institutional investors also increasing their positions.
	2024-11-13	+0.19 %
Organon & Co. (OGN) stock rose 0.19% due to increased interest from institutional investors and a recent positive rating from Evercore ISI despite a mixed earnings report.
	2024-11-04	-6.36 %
Organon & Co. (OGN) shares fell by 6.36% largely due to a downgrade from JPMorgan Chase & Co., which changed its rating from "neutral" to "underweight," despite a mixed earnings report and recent institutional trading activity.